Artzi Moran, Liberman Gilad, Blumenthal Deborah T, Aizenstein Orna, Bokstein Felix, Ben Bashat Dafna
Functional Brain Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Magn Reson Imaging. 2018 Jan 3. doi: 10.1002/jmri.25939.
High-grade gliomas (HGGs) induce both vasogenic edema and extensive infiltration of tumor cells, both of which present with similar appearance on conventional MRI. Using current radiological criteria, differentiation between these tumoral and nontumoral areas within the nonenhancing lesion area remains challenging.
To use radiomics patch-based analysis, based on conventional MRI, for the classification of the nonenhancing lesion area in patients with HGG into tumoral and nontumoral components.
Prospective.
In all, 179 MRI scans were obtained from 102 patients: 67 patients with HGG and 35 patients with brain metastases. A subgroup of 15 patients with HGG were scanned before and following administration of bevacizumab.
FIELD STRENGTH/SEQUENCE: Pre and postcontrast agent T -weighted-imaging (WI), T WI, FLAIR, diffusion-tensor-imaging (DTI), and dynamic-contrast-enhanced (DCE)-MRI at 3T.
A total of 225 histograms and gray-level-co-occurrence matrix-based features were extracted from the nonenhancing lesion area. Tumoral volumes of interest (VOIs) were defined at the peritumoral area in patients with HGG; nontumoral VOIs were defined in patients with brain metastasis. Twenty machine-learning algorithms including support-vector-machine (SVM), k-nearest neighbor, decision-trees, and ensemble classifiers were tested. The best classifier was trained on the entire labeled data, and was used to classify the entire data.
Dimensional reduction was performed on the 225 features using principal component analysis. Classification results were evaluated based on the sensitivity, specificity, and accuracy of each of the 20 classifiers, first based on a training and testing dataset (80% of the labeled data) in a 5-fold manner, and next by applying the best classifier to the validation data (the remaining 20% of the labeled data). Results were additionally evaluated by assessing differences in dynamic-contrast-enhanced plasma-volume (v ) and volume-transfer-constant (k ) values between the two components using Mann-Whitney U-test/t-test.
The best classification into tumoral and nontumoral lesion components was obtained using a linear SVM classifier, with average accuracy of 87%, sensitivity 86%, and specificity of 89% (for the training and testing data). Significantly higher v and k values (P < 0.0001) were detected in the tumoral compared to the nontumoral component. Preliminary classification results in a subgroup of patients treated with bevacizumab demonstrated a reduction mainly in the nontumoral component following administration of bevacizumab, enabling early assessment of disease progression in some patients.
A radiomics patch-based analysis enables classification of the nonenhancing lesion area in patients with HGG. Preliminary results were promising and the proposed method has the potential to assist in clinical decision-making and to improve therapy response assessment in patients with HGG.
1 Technical Efficacy Stage 4 J. Magn. Reson. Imaging 2018.
高级别胶质瘤(HGGs)可引发血管源性水肿和肿瘤细胞的广泛浸润,这两者在传统磁共振成像(MRI)上表现相似。依据当前的放射学标准,在非强化病变区域内区分这些肿瘤性和非肿瘤性区域仍具有挑战性。
基于传统MRI,运用基于放射组学斑块的分析方法,将HGG患者的非强化病变区域分类为肿瘤性和非肿瘤性成分。
前瞻性研究。
共从102例患者中获取了179次MRI扫描:67例HGG患者和35例脑转移患者。15例HGG患者的亚组在使用贝伐单抗前后进行了扫描。
场强/序列:3T下的造影剂前、后T加权成像(WI)、T2WI、液体衰减反转恢复序列(FLAIR)、扩散张量成像(DTI)以及动态对比增强(DCE)-MRI。
从非强化病变区域提取了总共225个直方图和基于灰度共生矩阵的特征。在HGG患者的瘤周区域定义肿瘤性感兴趣体积(VOIs);在脑转移患者中定义非肿瘤性VOIs。测试了包括支持向量机(SVM)、k近邻、决策树和集成分类器在内的20种机器学习算法。最佳分类器在全部标记数据上进行训练,并用于对整个数据进行分类。
使用主成分分析对225个特征进行降维。基于20种分类器各自的敏感性、特异性和准确性评估分类结果,首先基于训练和测试数据集(80%的标记数据)以5折交叉验证的方式进行评估,接着将最佳分类器应用于验证数据(其余20%的标记数据)。通过使用曼-惠特尼U检验/t检验评估两个成分之间动态对比增强血浆容量(v)和容积转运常数(k)值的差异,对结果进行额外评估。
使用线性SVM分类器对肿瘤性和非肿瘤性病变成分进行分类的效果最佳,(对于训练和测试数据)平均准确率为87%,敏感性为86%,特异性为89%。与非肿瘤性成分相比,在肿瘤性成分中检测到显著更高的v和k值(P < 0.0001)。在接受贝伐单抗治疗的患者亚组中的初步分类结果表明,使用贝伐单抗后主要是非肿瘤性成分减少,这使得能够在一些患者中早期评估疾病进展。
基于放射组学斑块的分析能够对HGG患者的非强化病变区域进行分类。初步结果很有前景,所提出的方法有可能协助临床决策并改善HGG患者的治疗反应评估。
1技术效能4期《磁共振成像杂志》2018年